We proposed that Ginsenoside Rg3 sensitized GC cells to cisplatin treatment through inhibiting SOX2 and the PI3K/AKT/mTOR signaling axis by up-regulating miR-429. The gene discussed is SOX2; the disease is gastric cancer.